FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
Article Related Press Releases (1) Related Articles (4) Related SEC Filings (1) Stock Quotes (1) Comments (0)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aegis Capital Starts Heron Therapeutics (HRTX) at Buy
- AstraZeneca (AZN) Announces Significant PFS Data from LYNPARZA Phase III SOLO-2
- Veracyte (VCYT) Announces Significant Data from Percepta Bronchial Genomic Classifier in Lung Cancer Screening
Create E-mail Alert Related CategoriesFDA, Insiders' Blog
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!